Axel Lipp

2.2k total citations
30 papers, 1.2k citations indexed

About

Axel Lipp is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Axel Lipp has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Neurology, 9 papers in Cellular and Molecular Neuroscience and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Axel Lipp's work include Parkinson's Disease Mechanisms and Treatments (17 papers), Neurological disorders and treatments (12 papers) and Botulinum Toxin and Related Neurological Disorders (7 papers). Axel Lipp is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (17 papers), Neurological disorders and treatments (12 papers) and Botulinum Toxin and Related Neurological Disorders (7 papers). Axel Lipp collaborates with scholars based in Germany, United States and United Kingdom. Axel Lipp's co-authors include Cornelia Noack, G. Arnold, Andreas Kupsch, Tania Schink, Thomas Trottenberg, Leonora Zange, Phillip A. Low, Paola Sandroni, Karsten Heusser and Ingolf Sack and has published in prestigious journals such as Circulation, NeuroImage and Brain.

In The Last Decade

Axel Lipp

30 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Axel Lipp Germany 19 712 300 246 166 162 30 1.2k
Kurt Kimpinski Canada 25 726 1.0× 437 1.5× 427 1.7× 388 2.3× 360 2.2× 66 1.8k
Regina Esterhammer Austria 25 1.2k 1.7× 489 1.6× 248 1.0× 214 1.3× 128 0.8× 41 2.0k
Michael Nocker Austria 19 626 0.9× 227 0.8× 124 0.5× 49 0.3× 101 0.6× 28 1.0k
Jos P. H. Reulen Netherlands 19 339 0.5× 254 0.8× 111 0.5× 57 0.3× 282 1.7× 28 1.1k
H. Marthol Germany 18 393 0.6× 75 0.3× 340 1.4× 139 0.8× 462 2.9× 38 1.1k
Elizabeth A. Coon United States 18 1.1k 1.6× 368 1.2× 232 0.9× 211 1.3× 302 1.9× 75 1.5k
Iris Reuter Germany 21 779 1.1× 274 0.9× 61 0.2× 88 0.5× 111 0.7× 56 1.4k
Birger Johnsen Denmark 22 729 1.0× 394 1.3× 32 0.1× 194 1.2× 175 1.1× 63 1.3k
Christoph Globas Germany 23 665 0.9× 671 2.2× 168 0.7× 132 0.8× 58 0.4× 37 1.4k
Iva Stanković Serbia 26 1.3k 1.9× 455 1.5× 71 0.3× 91 0.5× 231 1.4× 68 1.7k

Countries citing papers authored by Axel Lipp

Since Specialization
Citations

This map shows the geographic impact of Axel Lipp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Lipp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Lipp more than expected).

Fields of papers citing papers by Axel Lipp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Lipp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Lipp. The network helps show where Axel Lipp may publish in the future.

Co-authorship network of co-authors of Axel Lipp

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Lipp. A scholar is included among the top collaborators of Axel Lipp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Lipp. Axel Lipp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Müller, Thomas, Carsten Buhmann, Fabian Klostermann, et al.. (2024). Clinicians’ viewpoints on current paradigms of care and research in Parkinson’s disease. Journal of Neural Transmission. 131(12). 1455–1462. 2 indexed citations
2.
Otte, Karen, Daniel Kroneberg, Ludwig Rasche, et al.. (2020). Instrumental Assessment of Stepping in Place Captures Clinically Relevant Motor Symptoms of Parkinson’s Disease. Sensors. 20(19). 5465–5465. 8 indexed citations
3.
4.
Zange, Leonora, et al.. (2019). Cardiac 123I-MIBG Scintigraphy in Neurodegenerative Parkinson Syndromes: Performance and Pitfalls in Clinical Practice. Frontiers in Neurology. 10. 152–152. 30 indexed citations
5.
Lipp, Axel, et al.. (2018). Progressive supranuclear palsy and idiopathic Parkinson’s disease are associated with local reduction of in vivo brain viscoelasticity. European Radiology. 28(8). 3347–3354. 42 indexed citations
6.
Krause, Patricia, Axel Lipp, Andreas Horn, et al.. (2016). Long-term results of deep brain stimulation in a cohort of eight children with isolated dystonia. Journal of Neurology. 263(11). 2319–2326. 26 indexed citations
7.
Zange, Leonora, Cornelia Noack, Katrin Hahn, Werner Stenzel, & Axel Lipp. (2015). Phosphorylated α-synuclein in skin nerve fibres differentiates Parkinson’s disease from multiple system atrophy. Brain. 138(8). 2310–2321. 99 indexed citations
8.
Noack, Cornelia, Christoph Schroeder, Karsten Heusser, & Axel Lipp. (2014). Cardiovascular effects of levodopa in Parkinson's disease. Parkinsonism & Related Disorders. 20(8). 815–818. 67 indexed citations
9.
Nikulin, Vadim V., Tommaso Fedele, Jan Mehnert, et al.. (2014). Monochromatic Ultra-Slow (~0.1Hz) Oscillations in the human electroencephalogram and their relation to hemodynamics. NeuroImage. 97. 71–80. 41 indexed citations
10.
Lipp, Axel, Friedemann Paul, Andreas Fehlner, et al.. (2013). Cerebral magnetic resonance elastography in supranuclear palsy and idiopathic Parkinson's disease. NeuroImage Clinical. 3. 381–387. 82 indexed citations
11.
Iodice, Valeria, Axel Lipp, J. Eric Ahlskog, et al.. (2012). Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests. Journal of Neurology Neurosurgery & Psychiatry. 83(4). 453–459. 82 indexed citations
12.
Lipp, Axel, James D. Schmelzer, Phillip A. Low, Bruce D. Johnson, & Eduardo E. Benarroch. (2010). Ventilatory and Cardiovascular Responses to Hypercapnia and Hypoxia in Multiple-System Atrophy. Archives of Neurology. 67(2). 211–6. 16 indexed citations
13.
Lipp, Axel, Paola Sandroni, & Phillip A. Low. (2009). Systemic postganglionic adrenergic studies do not distinguish parkinson's disease from multiple system atrophy. Journal of the Neurological Sciences. 281(1-2). 15–19. 8 indexed citations
14.
Lipp, Axel, Paola Sandroni, J. Eric Ahlskog, et al.. (2009). Prospective Differentiation of Multiple System Atrophy From Parkinson Disease, With and Without Autonomic Failure. Archives of Neurology. 66(6). 742–50. 108 indexed citations
15.
Adams, Frauke, Michael Boschmann, Elmar Lobsien, et al.. (2008). Influences of levodopa on adipose tissue and skeletal muscle metabolism in patients with idiopathic Parkinson’s disease. European Journal of Clinical Pharmacology. 64(9). 863–870. 21 indexed citations
16.
May, Susanne, Sid Gilman, Ronald G. Thomas, et al.. (2007). Potential outcome measures and trial design issues for multiple system atrophy. Movement Disorders. 22(16). 2371–2377. 45 indexed citations
17.
Lipp, Axel, Paola Sandroni, J. Eric Ahlskog, et al.. (2007). Calf venous compliance in multiple system atrophy. American Journal of Physiology-Heart and Circulatory Physiology. 293(1). H260–H265. 9 indexed citations
18.
Arnold, G., Thomas Gasser, Alexander Storch, et al.. (2005). High doses of pergolide improve clinical global impression in advanced Parkinson's disease—A preliminary open label study. Archives of Gerontology and Geriatrics. 41(3). 239–253. 7 indexed citations
19.
Lipp, Axel, Jens Tank, Mandy Stoffels, et al.. (2003). Riluzole and blood pressurein multiple system atrophy. Clinical Autonomic Research. 13(4). 271–274. 3 indexed citations
20.
Lipp, Axel, Thomas Trottenberg, Tania Schink, Andreas Kupsch, & G. Arnold. (2003). A randomized trial of botulinum toxin A for treatment of drooling. Neurology. 61(9). 1279–1281. 159 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kurt Kimpinski Breakdown of academic impact, for papers by Regina Esterhammer Breakdown of academic impact, for papers by Michael Nocker Breakdown of academic impact, for papers by Jos P. H. Reulen Breakdown of academic impact, for papers by H. Marthol Breakdown of academic impact, for papers by Elizabeth A. Coon Breakdown of academic impact, for papers by Iris Reuter Breakdown of academic impact, for papers by Birger Johnsen Breakdown of academic impact, for papers by Christoph Globas Breakdown of academic impact, for papers by Iva Stanković
Rankless by CCL
2026